Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
The Lancet. Infectious Diseases|February 13, 2019
Antibody kinetics following vaccination with MenAfriVac: an analysis of serological data from randomised trialsMichael White, Olubukola Idoko, Samba Sow, et al.
Clinical and Vaccine Immunology : CVI|June 1, 2012
Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introductionDavid A Ishola, Ray Borrow, Helen Findlow, et al.
Thorax|March 1, 2012
Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumoniaThomas Bewick, Carmen Sheppard, Sonia Greenwood, et al.
The European Respiratory Journal|December 22, 2012
Serotypes associated with the development of pneumococcal para-pneumonic effusion in adultsThomas Bewick, Carmen Sheppard, Sonia Greenwood, et al.
Vaccine|August 13, 2013
Effectiveness of meningococcal serogroup C vaccine programmesRay Borrow, Raquel Abad, Caroline Trotter, et al.
Health Economics|October 15, 2015
Measuring Health Spillovers for Economic Evaluation: A Case Study in MeningitisHareth Al-Janabi, Job Van Exel, Werner Brouwer, et al.
Vaccine|September 11, 2022
Validation and use of a serum bactericidal antibody assay for Neisseria meningitidis serogroup X in a seroprevalence study in Niger, West AfricaSara Katz, Kelly Townsend-Payne, Jennifer Louth, et al.
Vaccine|February 11, 2014
Clinical features of adults with seven-valent-conjugated-vaccine-serotype pneumococcal pneumoniaChamira Rodrigo, Thomas Bewick, Carmen Sheppard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2021
Every Country, Every Family: Time to Act for Group B Streptococcal Disease WorldwideJoy E Lawn, Jaya Chandna, Proma Paul, et al.
Vaccine|February 15, 2018
13-Valent vaccine serotype pneumococcal community acquired pneumonia in adults in high clinical risk groupsPriya Daniel, Chamira Rodrigo, Thomas Bewick, et al.
Pageof 8